{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-127560","form_type":"8-K","ticker":"ACET","cik":"0001720580","company_name":"Adicet Bio, Inc.","filed_at":"2024-11-15T23:59:59+00:00","discovered_at":"2026-05-14T18:03:09.357361+00:00","generated_at":"2026-05-29T23:50:11.077036+00:00","sec_items":["1.01","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Adicet Bio amends loan agreement to remove Adicet Shanghai shares from collateral, allow $500K transfers","bullets":["Eighth Amendment to loan with Banc of California (formerly Pacific Western Bank) dated Nov 8, 2024.","Equity interests in Adicet Shanghai removed from pledged collateral; no security interest on those shares.","Permitted investment threshold for cash transfers to Adicet Shanghai increased to $500,000 without bank approval.","Other amendments include deletion of Success Fee provisions and update of bank name to Banc of California."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-127560","json":"https://secwatch.observer/filing/0000950170-24-127560.json","markdown":"https://secwatch.observer/filing/0000950170-24-127560.md","text":"https://secwatch.observer/filing/0000950170-24-127560.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1720580/000095017024127560/0000950170-24-127560-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1720580/000095017024127560/acet-20241108.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-29T23:50:11.077036+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}